The National Graduate School in Infection Biology and Antimicrobials (or IBA) is a research school (forskerskole) funded by the Research Council of Norway, coordinated at the University of Oslo. Both PhD students and postdocs registered at Norwegian universities are welcome to apply for membership in IBA. Our program funds courses and workshops and research stays abroad/in Norway, has annual networking meetings, and we support participation in these activities by co-funding of travel and accommodation costs.
Latest news:
IBA webinar: how to plan a grant proposal
2020-05-15 12:47:45Do you want to learn how and when to plan a grant application?
Read more here
Registration: link
We have invited Jørgen Kirksæther to talk about how to begin and how to improve existing applications.
All members are welcome.
Jørgen Kirksæther works as a senior adviser in the Section for Research at the Faculty of Mathematics and Natural Sciences at UiO. His fields of expertise is project administration and development, as well as application guidance.
Online course on Scientific Writing
2020-04-08 11:59:26IBA offers a course on Scientific Writing from April 20-24th. The course is meant to provide a virtual space to meet up, learn and talk about your writing during these unconventional times.
Instructor: Mathew Stiller-Reeve.
Focus Covid 19: webinar of potential interest to IBA members and faculties
2020-03-27 16:18:34Free online MIT seminar entitled “Dealing with Coronavirus: An Industry Perspective”. Wed, April 1, 2020, 10:30 PM – 12:00 PM CET.
Given by Stéphane Bancel, CEO of Moderna. Hosted by the MIT Sloan School of Management (Boston).
Link for info and registration: https://mitsloan.mit.edu/events/2020-04-01-dealing-coronavirus-industry-perspective
Background: After just 42 days, Moderna produced a batch of vaccines ready for clinical trials- from sequence identification through vaccine design, manufacturing, and shipment.
Co-hosted by MIT’s Laboratory for Financial Engineering and Golub Center for Finance and Policy, join a conversation with Stéphane Bancel, CEO of Moderna, as he describes the science, business, and policy issues surrounding the first and currently only company with a vaccine for coronavirus in clinical trials at the National Institute of Health (NIH).
The project is also funded by The Coalition for Epidemic Preparedness Innovations (CEPI), headquartered in Oslo.
Update on the current situation and online course information
2020-03-20 14:22:12To our members:
We hope that you all are well and that you are settling into working at home, social distancing and the new reality created by the coronavirus situation.
As the Universities and laboratories are temporarily closed, we need to explore alternative means to effectuating IBA goals and services. In that context, we want to take this opportunity to remind you of the online course on Effective Collaboration in Research from Nature Masterclass.
Check out this YouTube video for more information:
In this highly-rated on-line course, you can learn how to join, set up and lead collaborative research projects at your own pace.
We look forward to working with you on this and other alternative learning and career developing activities in these “interesting” times.
To get access to the online course contact tina.svingerud@ibv.uio.no
Happy holidays from IBA
2019-12-20 10:52:19It is December and we want to wish you all a Merry Christmas and a Happy New Year!
We have several events in the planning for 2020 including:
- One week intensive international course on Antimicrobial Resistance
- Nature MasterClass writing course
- Lyme disease symposium
- Workshops on molecular and clinical aspects of infection biology, antimicrobials, inflammation and immunity
- Regional networking and career development events
In addition, we offer financial support for participation in international courses and research travel.
So stay tuned.